Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Have a Cow! And an Egg, Too!

    A high saturated-fat and no-starch diet resulted in modest weight loss without negative effects on serum lipid levels; weight loss can be continued for up to a year with such a diet.
  • Full January 2004 Issue in PDF

  • Pharmacology Watch: Vioxx Might Control Postoperative Knee Pain

    Oral rofecoxib (Vioxx) may have a role in controlling postoperative pain patients undergoing knee surgery. Researchers in Chicago enrolled 70 patients who were undergoing total knee arthroplasty and randomized them to rofecoxib 50 mg the day prior to surgery, 1-2 hours prior to surgery, and for 5 days postoperatively, then 25 mg daily for another 8 days; or matching placebo at the same times.
  • Updates

    An outbreak of tetanus involving 6 (and possibly 7) injection drug users in England and Wales has officials concerned that others may be at risk. Six of the cases occurred during the past 3 weeks and were spread throughout the country, suggesting contamination of some type of drugpossibly heroin.
  • In a Community Near You: MRSA 

    The evolution of antibiotic resistance in Staphylococcus aureus is an epic saga. Resistance to penicillin was first reported in the 1940s, at a time when the drug still remained in short supply.
  • ICAAC/IDSA/ASTMH 2003

    The following summary of selected abstracts from 3 meetings will be published in multiple parts. The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) met in Chicago September 14-17, 2003.
  • Large drug copayment increases lead to decreased utilization

    Pharmacists may expect their patients to switch to less expensive drugs when their copayments increase dramatically. A recent study, however, suggests that some patients may stop taking their important medications altogether.
  • News Briefs

    Pediatric rule legislation passes Congress; Aggressive atorvastatin therapy halts progression of atherosclerosis; New indications for valganciclovir HCl tablets; Aventis warns of hepatic injury reports with leflunomide (Arava); Seniors most vulnerable to hospital medication errors
  • IDSA suggests initial empiric therapy for CAP

    In the 2003 recommendations for management of community-acquired pneumonia (CAP) in immunocompetent adults, the Infectious Diseases Society of America (IDSA) in Alexandria, VA, has issued suggestions for initial empiric therapy.
  • Full January 2004 Issue in PDF